Spots Global Cancer Trial Database for Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
Official Title: Phase IB Study to Evaluate the Biological Activity of Indibulin Using Positron-Emission Tomography (PET) Scans
Study ID: NCT00591890
Conditions
Interventions
Study Description
Brief Summary: Single arm, open label, Phase IB study of indibulin capsules in subjects with advanced solid tumors; eligible subjects will have a baseline PET scan showing a standardized uptake value (SUV) of ≥5.0 in ≥1 lesion on an 18F-FDG (fluorine-18-labeled deoxyglucose) scale.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Santa Monica, California, United States
Contact Details
Name: Jonathan Lewis, MD
Affiliation: Alaunos Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
